首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Jgh open

缩写:

ISSN:2397-9070

e-ISSN:2397-9070

IF/分区:1.6/Q4

文章目录 更多期刊信息

共收录本刊相关文章索引1449条
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
R Gilmore,T Pham,R G Fernandes et al. R Gilmore et al.
Background and aims: Tofacitinib, an oral Janus Kinase (JAK) inhibitor, has demonstrated efficacy for ulcerative colitis (UC) in clinical trials, but the optimal dosing regimen remains unclear. This study aims to assess t...
Chun Ho Szeto,Gloria Erazo Montalvan,Chung Yin Tai et al. Chun Ho Szeto et al.
Background: Idiopathic pulmonary fibrosis (IPF) is a progressive lung disease with poor prognosis. Patients with IPF are frequently exposed to risk factors for Clostridium difficile infection (CDI), such as advanced age, ...
R M Mathias,S L Plush,L E Edwards et al. R M Mathias et al.
Background: Disorders of gut-brain interaction (DGBI) affect approximately 40% of the global population. Multidisciplinary models incorporating dietetic management are increasingly used, yet objective assessment tools rem...
Rishi Chowdhary,Manjeet Kumar Goyal,Kirti Arora et al. Rishi Chowdhary et al.
The gut microbiota is a dynamic community of bacteria, viruses, fungi, and archaea that plays a pivotal role in regulating host immunity, metabolism, and systemic homeostasis. Dysbiosis, characterized by an imbalance in the microbial compos...
Yosuke Yamada,Natsuki Ishida,Tomohiro Takebe et al. Yosuke Yamada et al.
Aim: Fecal occult blood concentration, fecal calprotectin (FC) level, serum C-reactive protein (CRP) level, and erythrocyte sedimentation rate (ESR) are valuable biomarkers for ulcerative colitis (UC). However, their clin...
Makoto Furuya,Kiichiro Yoza,Takeshi Yonezawa et al. Makoto Furuya et al.
Background/aims: The subcutaneous (SC) formulation of vedolizumab is available as an alternative to the intravenous (IV) formulation in patients with ulcerative colitis (UC). However, data from Asian patients are limited,...
Ziyi Zhao,Jinlian Ling,Jiashu Chen Ziyi Zhao
Background: Constipation affects approximately 15.3% of the global population. While the gut microbiome's role in constipation has been studied, the causal relationship between the oral microbiome and constipation remains...
Fangjie Fu,Chen Zhang,Zhengying Xu et al. Fangjie Fu et al.
Sepsis, characterized by life-threatening organ dysfunction resulting from an uncontrolled response to infection, can impact various systems of the body, including the digestive system. Prior research has identified sepsis as a significant ...
Faris Chater,Maja Kopczynska,Mahdi Saeidinejad et al. Faris Chater et al.
Objectives: The success of anti-TNFα agents has changed the landscape of treatment for inflammatory bowel diseases (IBD). One major limitation to this success is the secondary loss of response (sLOR) phenomenon. Combinat...
F N U Eman,F N U Gyaneshwari,Raveena Kumari et al. F N U Eman et al.
Background: Colorectal cancer (CRC) is a major global health issue, with adenomatous polyps as the main precursors. Standard colonoscopy is the gold standard, but its effectiveness is limited by operator variability and m...